Engineering BHK-21 cells by dual knockout of host-restriction factors Cav1 and HDAC6 achieved a marked increase in FMDV titers for scalable vaccine production
ABSTRACT Foot-and-mouth disease virus (FMDV) vaccine production depends on BHK-21 cells, but the high antigen dose required for biannual mass vaccination campaigns using an inactivated vaccine limits global vaccine supply. In this study, a targeted small-molecule screen identified baicalein (caveolin-1 inhibitor) and tubacin (HDAC6 inhibitor) as potent enhancers of FMDV replication in BHK-21 cells. Cav1 was shown to act as an early restriction factor: its inhibition increased the viral entry and consequently produced a sixfold higher virus yield. Cav1 inhibition also primed p53-dependent intrinsic apoptosis, raising p53 phosphorylation and BAX/BIM transcripts, shifting cells into early apoptosis, and promoting cytolytic spread. HDAC6 was shown to function as a post-entry restriction factor: its inhibition elevated α-tubulin acetylation, enhancing viral RNA and protein expression and producing four to six times titer boost. Finally, using CRISPR/Cas9, we generated Cav1/HDAC6 double-knockout (dKO) BHK-21 cells , targeting two host restriction factors that impose entry and post-entry barriers to FMDV replication. The engineered BHK-21 cells in both adherent and suspension culture formats produced 10- to 20-fold higher virus titers across field FMDV serotype “O” and FMDV vaccine strains of serotypes “O,” “A,” and “Asia 1.” Reintroducing either factor restored restriction, confirming their roles as host restriction factors. These findings reveal a dual-layer host defense mechanism and establish an engineered, high-yield BHK-21 cell line for enhanced viral production and improved vaccine manufacturing efficiency. IMPORTANCE Foot-and-mouth disease (FMD) imposes substantial economic losses on livestock-producing countries through reduced animal productivity and trade restrictions. Control relies on biannual herd vaccination, generating a demand for vaccine that often exceeds current manufacturing capacity. FMD vaccine antigen is conventionally produced in BHK-21 cells; however, limited viral yields increase production costs and constrain supply. Here, we identify caveolin-1 and HDAC6 as host restriction factors for foot-and-mouth disease virus (FMDV) in BHK-21 cells. Caveolin-1 restricts FMDV at the entry stage, whereas HDAC6 acts at a post-entry step. Knockout of these factors enhances viral yields by 10- to 20-fold across FMDV serotypes O, A, and Asia 1—the three serotypes included in India’s trivalent vaccine program. These findings indicate that BHK-21 cells deficient in caveolin-1 and HDAC6 could substantially improve FMDV propagation and provide a scalable, cost-effective platform for vaccine manufacturing.
Authors
- Supriya Bhattacharya
- Nitin Khandelwal (ORCID: https://orcid.org/0000-0001-7229-4413)
- Alka Nokhwal (ORCID: https://orcid.org/0000-0002-1653-8468)
- Sreenivasulu Kilari (ORCID: https://orcid.org/0000-0002-9149-7360)
- Naveen Kumar (ORCID: https://orcid.org/0000-0003-3974-9409)
- Yogesh Chander (ORCID: https://orcid.org/0000-0001-7869-9067)
- Himanshu Kamboj (ORCID: https://orcid.org/0000-0002-2650-5563)
- Assim Verma (ORCID: https://orcid.org/0009-0006-9651-3055)
- Garvit Kumar
- Riyesh T
Institutions
- National Research Centre on Equines (IN)
- ICMR-National Institute of Virology (IN)
Publication Details
- Journal
- Journal of Virology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1128/jvi.01164-26
- Primary Topic
- Animal Disease Management and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Department of Biotechnology, Ministry of Science and Technology, India